Ochieng J, Warfield P, Green B
Department of Biochemistry, Meharry Medical College, Nashville, Tennessee 37208, USA.
Arch Biochem Biophys. 1995 Sep 10;322(1):250-5. doi: 10.1006/abbi.1995.1459.
We have analyzed the interactions of human and mouse gelatinases with fetuin and asialofetuin. The data showed that recombinant human gelatinase A (MMP-2) and B (MMP-9) were both specifically bound to asialofetuin and fetuin immobilized to activated agarose (affigel) with subsequent cleavage of the enzymes to lower molecular weight forms, which were likewise bound to asialofetuin/fetuin. The binding of gelatinases to immobilized forms of asialofetuin and fetuins was abrogated in the presence of either soluble fetuin or asialofetuin. Endogenous mouse macrophage gelatinases (mol wt 92 and approximately 52 kDa) were also specifically bound to immobilized asialofetuin upon which the two forms of the gelatinases were reduced to a approximately 45-kDa fragment. The binding of the approximately 45-kDa fragment to asialofetuin was also abrogated in the presence of either soluble fetuin or asialofetuin. Whereas only the activated MMP-2 bound to immobilized asialofetuin had significant gelatinolytic activity, both the zymogen and the activated forms of MMP-9 hydrolyzed soluble [3H]gelatin to the same extent while still bound to asialofetuin. Our data suggest that cell surface bound fetuin/asialofetuin could perform two functions: they could (a) act as cell surface receptors or anchors for MMP-2 and MMP-9 and (b) bind and activate MMP-9 on the cell surface.
我们分析了人源和鼠源明胶酶与胎球蛋白及去唾液酸胎球蛋白的相互作用。数据表明,重组人明胶酶A(基质金属蛋白酶-2,MMP-2)和B(基质金属蛋白酶-9,MMP-9)均能特异性结合固定于活化琼脂糖(Affigel)上的去唾液酸胎球蛋白和胎球蛋白,随后酶被切割成分子量更低的形式,这些低分子量形式同样能与去唾液酸胎球蛋白/胎球蛋白结合。在可溶性胎球蛋白或去唾液酸胎球蛋白存在的情况下,明胶酶与固定化形式的去唾液酸胎球蛋白和胎球蛋白的结合被消除。内源性小鼠巨噬细胞明胶酶(分子量分别为92 kDa和约52 kDa)也能特异性结合固定化的去唾液酸胎球蛋白,在此过程中这两种形式的明胶酶被还原为约45 kDa的片段。在可溶性胎球蛋白或去唾液酸胎球蛋白存在的情况下,约45 kDa片段与去唾液酸胎球蛋白的结合也被消除。虽然只有与固定化去唾液酸胎球蛋白结合的活化MMP-2具有显著的明胶水解活性,但MMP-9的酶原形式和活化形式在仍与去唾液酸胎球蛋白结合时,对可溶性[3H]明胶的水解程度相同。我们的数据表明,细胞表面结合的胎球蛋白/去唾液酸胎球蛋白可发挥两种功能:它们可以(a)作为MMP-2和MMP-9的细胞表面受体或锚定物,以及(b)在细胞表面结合并激活MMP-9。